Treatment goals in psoriasis routine care
- 31 December 2014
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 307 (5) , 445-449
Abstract
The treatment goal algorithm for psoriasis, first originated in 2007, has ever since been adopted into treatment guidelines. It remained unclear how many patients have experienced the use of treatment goals in routine care and how these are perceived. The aim of the pilot study was to get first insight in the use and impact of therapeutic goals in a large cohort of patients with psoriasis in routine care. This study is a multicenter, non-interventional, cross-sectional health care study in n = 213 dermatology centers across Germany. A standardized physician and patient questionnaire was used, including demographics, disease and treatment characteristics. To evaluate patient treatment perception and satisfaction, a questionnaire (PsoSat) addressing 8 specific items was designed. Consistency and validity of the questionnaire were controlled by factor analyses and reliability tests. In total n = 1,883 patients were included for analysis (54.2 % male). Mean age was 52 years, mean disease duration 19 years. In total 45.5 % (n = 856) stated an improvement of psoriatic symptoms in the last 4 weeks. In patients including treatment goals, the course of psoriasis in the last 4 weeks was rated significantly better and predicted significantly higher patient satisfaction. Patients reporting periodic outcomes measurement of psoriasis treatment, also had significantly better course of disease, higher satisfaction and a lower psoriasis severity. A majority of patients experienced the use of treatment goals in practice. The association of using treatment goals with clinical outcomes and treatment satisfaction was markedly positive. These findings indicate that the use of treatment goals and outcome measurements in fact improve psoriasis management.Keywords
This publication has 11 references indexed in Scilit:
- Implementing therapeutic goals in maintenance treatment of psoriasis with biologics: adalimumab can be more cost-effective than infliximab or ustekinumab in real lifeEuropean Journal Of Dermatology, 2013
- An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goalsBritish Journal of Dermatology, 2012
- Induction phase, primary endpoint, time to decide on primary failure, and therapeutic goals in biologic treatment of psoriasisJournal of the European Academy of Dermatology and Venereology, 2012
- S3 – Guidelines on the treatment of psoriasis vulgaris (English version). UpdateJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2012
- Implementing treatment goals for successful long‐term management of psoriasisJournal of the European Academy of Dermatology and Venereology, 2012
- Strategies for improving the quality of care in psoriasis with the use of treatment goals – a report on an implementation meetingJournal of the European Academy of Dermatology and Venereology, 2011
- Definition of treatment goals for moderate to severe psoriasis: a European consensusArchives of Dermatological Research, 2010
- Evaluation of Quality of Care and Guideline-Compliant Treatment in PsoriasisDermatology, 2009
- Quality of psoriasis care in Germany – results of the national study PsoHealth 2007JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2008
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994